Aarti Drugs surges 13% as board mulls share buyback on August 26

Quick Summary:

Going ahead in FY25, the management anticipates an improvement in margins, mostly driven by an anticipated growth in export sales and backward integration.

The rational behind the companies that announced buyback is to reward its shareholders and enhance the overall return to shareholders.

A buyback is a company's purchase of its outstanding stock shares.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Active pharmaceutical ingredients Aarti Drugs stock price today Aarti Drugs share price today Aarti Drugs share price Aarti drugs share price today August 22 2024 Aarti Drugs Pharmaceutical Shares today APIs business share market today

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-22 @ 10:56:31 (8 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 532 words

Reading Time: 3 minutes read

Sentences: 22 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22203279

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 297 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions